Lymphocyte activation via NKG2D: Towards a new paradigm in immune recognition?

Current Opinion in Immunology

Volumn 14, Issue 3, 2002, Pages 306-311

  Vivier, Eric ^a   Tomasello, Elena ^a   Paul, Pascale ^a  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CD8 ANTIGEN; CELL SURFACE RECEPTOR; GLYCOSYLPHOSPHATIDYLINOSITOL; NATURAL KILLER CELL RECEPTOR NKG2D; RETINOIC ACID; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; EFFECTOR CELL; HUMAN; LYMPHOCYTE ACTIVATION; MOLECULAR RECOGNITION; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECEPTOR UPREGULATION; REVIEW; T LYMPHOCYTE;

EID: 0036604988     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(02)00337-0     Document Type: Review

References (49)

1. Signaling pathways engaged by NK cell receptors: Double concerto for activating receptors, inhibitory receptors and NK cells
2. Natural killer cells, viruses and cancer
3. What is a natural killer cell?
4. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
5. Vital involvement of a natural killer cell activation receptor in resistance to viral infection
6. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily
7. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H
8. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells
9. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
10. An activating immunoreceptor complex formed by NKG2D and DAP10
11. The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex
12. Murine NKG2D and CD94 are clustered within the natural killer complex and are expressed independently in natural killer cells
13. Molecular cloning and characterization of pig immunoreceptor DAP10 and NKG2D
14. Homologues of natural killer cell receptors NKG2-D and NKR-P1 expressed in cattle
15. Conservation and variation in human and common chimpanzee CD94 and NKG2 genes
16. Characterization of rhesus monkey CD94/NKG2 family members and identification of novel transmembrane-deleted forms of NKG2-A,B,C and D
17. Molecular characterization of rat NKR-P2, a lectin-like receptor expressed by NK cells and resting T cells
18. Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A
19. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages
20. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells
21. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment
22. Regulation of cutaneous malignancy by gamma delta T cells
23. The molecular and functional characterization of a dominant minor H antigen, H60
24. Genomic structures and characterization of Rae1 family members encoding GPI-anchored cell surface proteins and expressed predominantly in embryonic mouse brain
25. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice
26. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
27. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
28. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
29. MICA and MICB genes: Can the enigma of their polymorphism be resolved?
30. Oxidative stress increases MICA and MICB gene expression in the human colon carcinoma cell line (CaCo-2)
31. MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function
32. Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes
33. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA
34. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
35. A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3
36. Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3
37. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA
38. Crystal structures of RAE-1 beta and its complex with the activating immunoreceptor NKG2D
39. Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60
40. Ligands for murine NKG2D display heterogeneous binding behavior
41. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions
42. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family
43. ULBP1,2,3: Novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells
44. KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties
45. Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin
46. Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs
47. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells
48. Multifaceted roles of MHC class I and MHC class I-like molecules in T cell activation
49. High levels of RAE-1 isoforms on mouse tumor cell lines assessed by anti-'pan' RAE-1 antibody confer tumor susceptibility to NK cells